Severe methotrexate hypersensitivity during treatment for Gestational trophoblastic Neoplasia: Case Report and considerations for management.
Severe methotrexate hypersensitivity during treatment for Gestational trophoblastic Neoplasia: Case Report and considerations for management. Gynecol Oncol Rep. 2024 Apr; 52:101364.
PMID: 38495802
Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data.
Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data. Lancet Healthy Longev. 2023 11; 4(11):e591-e599.
PMID: 37924840
The Hitchhiker's guide to longitudinal models: A primer on model selection for repeated-measures methods.
The Hitchhiker's guide to longitudinal models: A primer on model selection for repeated-measures methods. Dev Cogn Neurosci. 2023 Oct; 63:101281.
PMID: 37536082
Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings.
Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings. Int J Geriatr Psychiatry. 2023 01; 38(1):e5878.
PMID: 36704984
Ovarian Masses: The Value of Acoustic Shadowing on Ultrasound Examination.
Ovarian Masses: The Value of Acoustic Shadowing on Ultrasound Examination. J Ultrasound Med. 2023 Apr; 42(4):935-945.
PMID: 36114807
Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer.
Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer. JCO Oncol Pract. 2022 06; 18(6):e948-e957.
PMID: 35201895
Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer.
Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer. CA Cancer J Clin. 2022 03; 72(2):102-111.
PMID: 35077576
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers? Gynecol Oncol. 2020 06; 157(3):706-710.
PMID: 32143914
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab.
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab. Gynecol Oncol Rep. 2019 Nov; 30:100502.
PMID: 31720357
Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter.
Grozio A, Mills K, Yoshino J, Bruzzone S, Sociali G, Tokizane K, Lei HC, Sasaki Y, Migaud M, Imai SI. Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter. Nat Metab. 2019 07; 1(7):662-665.
PMID: 32694650